top of page
Search

Hyperbaric oxygen therapy increases norepinephrine levels for the treatment of Parkinson’s Disease

  • o2lifehyperbarics
  • Jan 30, 2023
  • 1 min read

Tissue concentrations of norepinephrine (NE) are markedly decreased in various regions of the brain in Parkinson patients. Not only is NE involved in cognitive operations, "freezing" of gait, tremor, dyskinesia, REM sleep regulation, and other aspects of brain function, but evidence also suggest its role in the neurodegenerative process itself. This study discusses the ability of hyperbaric oxygen therapy to help increase NE levels in the brain; thereby, helping to restore motor deficits in Parkinson’s disease patients.


 
 
 

Comments


  • Facebook
  • Instagram

©2020 by O2 Life LLC. Proudly created with Wix.com
The information provided on this site is intended for your general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. You should not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition.

bottom of page